This HTML5 document contains 188 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://dx.doi.org/10.1038/
n8http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
n13https://scigraph.springernature.com/pub.10.1038/
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q43246067
rdf:type
wikibase:Item
schema:description
2009 nî lūn-bûn tudományos cikk artículo científico publicado en 2009 scientific article published on 9 November 2009 2009年学术文章 ৯ নভেম্বর ২০০৯-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ artigo científico 2009年學術文章 artikulong pang-agham articol științific 2009年学术文章 scientific article published on 9 November 2009 vedecký článok artykuł naukowy 2009年学术文章 2009年学术文章 artikel ilmiah научни чланак научная статья vitskapeleg artikkel wissenschaftlicher Artikel מאמר מדעי teaduslik artikkel scienca artikolo 2009年學術文章 article scientifique article scientific 2009 թվականի նոյեմբերի 9-ին հրատարակված գիտական հոդված wetenschappelijk artikel vědecký článek naučni članak scientific article published on 9 November 2009 tieteellinen artikkeli articolo scientifico vitenskapelig artikkel 2009年学术文章 บทความทางวิทยาศาสตร์ bài báo khoa học 2009年學術文章 სამეცნიერო სტატია artikull shkencor مقالة علمية نشرت في 9 نوفمبر 2009 bilimsel makale 2009年学术文章 artigo científico article científic vetenskaplig artikel научна статия наукова стаття, опублікована в листопаді 2009 επιστημονικό άρθρο научни чланак 2009년 논문 2009年學術文章 artigo científico artículu científicu espublizáu en 2009 2009年學術文章 2009年の論文 videnskabelig artikel мақолаи илмӣ
p:P577
wds:Q43246067-34FB8DEA-8ED6-4B57-A8A4-6BC307330418
wdt:P577
2009-11-09T00:00:00Z
p:P407
wds:Q43246067-E30582DE-0181-4188-8C23-E62C25EFDBA0
wdt:P407
wd:Q1860
p:P2888
wds:Q43246067-FD6F3DFC-A500-493E-9DC3-8A6D1138BA39
wdt:P2888
n13:bmt.2009.318
p:P2860
wds:Q43246067-244C6A34-9396-42A1-B962-46EC5BA97BD7 wds:Q43246067-274C60D6-6384-4395-9E72-88F84336B608 wds:Q43246067-276C4FD5-9DFA-4408-AD4C-06C00D51D843 wds:Q43246067-1A28AB98-4C70-4B25-8C68-F9548FAA4163 wds:Q43246067-1AEFAF06-C75D-4C9C-A526-D25E5E0576FC wds:Q43246067-1DE67240-14E1-4BE1-8955-5BC9F0286D52 wds:Q43246067-097143AE-0EAF-4059-B0C6-6FEE3E6EFE3C wds:Q43246067-097BFE82-F0DB-4823-8E69-C072B94F98B7 wds:Q43246067-63098BF1-5044-48F0-BF5F-F3B51169F16B wds:Q43246067-67884027-F30F-4743-AB8D-1AF8D4340A2D wds:Q43246067-778316FA-E444-4C70-8D28-1C22D788D4EF wds:Q43246067-4B2EA4EB-17A5-4596-A88B-87155EE67967 wds:Q43246067-59729987-699D-4ED3-B990-9A8B41B40789 wds:Q43246067-601D4CD8-9121-4AAE-8C99-88F1245C95FC wds:Q43246067-366BD878-4311-49FE-A156-E578DBCA9E27 wds:Q43246067-37779165-E506-4D4E-97C2-6178567E9EE9 wds:Q43246067-3ECD0D7D-2BBA-4477-8FB0-410522033F1B wds:Q43246067-45CFCE11-DBB3-40FE-A7FA-FE9BA472294D wds:Q43246067-2FE71947-1843-4914-8533-325757DE0D2D wds:Q43246067-31B7558B-CB19-4D4C-8D59-4883AAF20024 wds:Q43246067-BDA974C6-F958-455F-8084-C30F65464427 wds:Q43246067-C486011B-D15F-4D1A-BD2F-B8A469C1E170 wds:Q43246067-B1A32FD8-5D74-4C5F-B545-AE922069110E wds:Q43246067-B1D36162-F5C1-4064-B08F-B09DF56E0D22 wds:Q43246067-95F4757A-917B-4768-8AA0-4C2229BC1409 wds:Q43246067-7E5F4448-0BDF-4A0C-9DD2-BAF94C6239B7 wds:Q43246067-80BDEA14-7FB2-4BDB-BD0B-4E4821CEB6C2 wds:Q43246067-E5D7E733-FCF9-46FA-9F7B-B93AFC1F7667 wds:Q43246067-EEFCB903-B5BD-4132-A239-C9DA23116DDA wds:Q43246067-F1EC0163-84DF-476D-965F-435A3E30AC0C wds:Q43246067-CC28EC3A-79CF-40F9-A153-5C340F1CE40C wds:Q43246067-CE024F57-D944-4A12-BB1E-77333AE6B05D wds:Q43246067-CA0A23EC-0ED9-4360-965B-1AE4FB0FB2B2 wds:Q43246067-CBFA074E-B213-4A5A-A39D-091F8CB2A303
wdt:P2860
wd:Q71053662 wd:Q46238714 wd:Q33382912 wd:Q36858857 wd:Q44391203 wd:Q37085060 wd:Q46147410 wd:Q46758755 wd:Q33985347 wd:Q33379858 wd:Q37307954 wd:Q44548374 wd:Q34057451 wd:Q58865926 wd:Q73740225 wd:Q44746182 wd:Q34589592 wd:Q73626976 wd:Q69748687 wd:Q73786509 wd:Q33347091 wd:Q36981909 wd:Q37125119 wd:Q57786613 wd:Q33773306 wd:Q50682353 wd:Q54178169 wd:Q79518266 wd:Q69781561 wd:Q42390557 wd:Q37086162 wd:Q67900311 wd:Q46239066 wd:Q42247542
p:P2093
wds:Q43246067-C57B58D2-B4E7-43CC-8ED5-FD4C60481E64 wds:Q43246067-C2E1616D-E717-4D23-9B63-DB1DB67687A6 wds:Q43246067-7AC55FD5-DD94-4276-A749-CF0E199FCDE4 wds:Q43246067-59EB5BC1-C679-42CA-9427-13DE77803BEB wds:Q43246067-2B82A7AC-16CC-43AD-AA07-92884B728570 wds:Q43246067-2625D15F-ABA0-43AF-AF81-D9BDA6B8A43E wds:Q43246067-FDB20071-DE63-4E02-A71B-8341B9AE717A wds:Q43246067-F64AB0ED-A644-4530-80AE-10BC845896E0 wds:Q43246067-C663BED0-C221-4100-81D5-4E348251EAD1 wds:Q43246067-C8271A4D-5CF0-4A05-A9D4-58748F12CE66
wdt:P2093
R Scalone A Crescimanno P Di Bartolomeo N Di Renzo N Cascavilla F Lanza A Pinto G Marcacci T Perrone M Musso
rdfs:label
Fotemustine plus etoposide, cytarabine and melphalan (FEAM) as a new conditioning regimen for lymphoma patients undergoing auto-SCT: a multicenter feasibility study Fotemustine plus etoposide, cytarabine and melphalan (FEAM) as a new conditioning regimen for lymphoma patients undergoing auto-SCT: a multicenter feasibility study
skos:prefLabel
Fotemustine plus etoposide, cytarabine and melphalan (FEAM) as a new conditioning regimen for lymphoma patients undergoing auto-SCT: a multicenter feasibility study Fotemustine plus etoposide, cytarabine and melphalan (FEAM) as a new conditioning regimen for lymphoma patients undergoing auto-SCT: a multicenter feasibility study
schema:name
Fotemustine plus etoposide, cytarabine and melphalan (FEAM) as a new conditioning regimen for lymphoma patients undergoing auto-SCT: a multicenter feasibility study Fotemustine plus etoposide, cytarabine and melphalan (FEAM) as a new conditioning regimen for lymphoma patients undergoing auto-SCT: a multicenter feasibility study
p:P1476
wds:Q43246067-D8527E5A-D555-4CD5-9D6E-9B5B8352EBDC
wdt:P1476
Fotemustine plus etoposide, cytarabine and melphalan (FEAM) as a new conditioning regimen for lymphoma patients undergoing auto-SCT: a multicenter feasibility study
p:P304
wds:Q43246067-7E42EDA5-63BE-4F84-9435-42992C58D0AD
wdt:P304
1147-1153
p:P31
wds:Q43246067-08C4E2C7-D803-4849-B1FE-03707AECAF55
wdt:P31
wd:Q13442814
p:P921
wds:Q43246067-B087AC71-5033-45A3-B4E4-E698B8D5A605 wds:Q43246067-222AA005-46A3-4040-AEC0-5FF4C332A725 wds:Q43246067-E3AD6F7B-7695-4C06-A4AB-C178C3806F8D
wdt:P921
wd:Q418817 wd:Q755009 wd:Q180983
p:P698
wds:Q43246067-BB962E3E-C1A1-4E2A-9135-7704E9D522DC
wdtn:P698
n8:19898504
wdt:P698
19898504
p:P1433
wds:Q43246067-88061B8E-DE52-4433-BE44-C83115F47B04
wdt:P1433
wd:Q4941523
p:P433
wds:Q43246067-76C6288B-15AF-46F4-A4FB-19D4BFCAF3E4
p:P478
wds:Q43246067-82280CF2-2576-49F1-B90A-43BF9117F51C
wdt:P433
7
wdt:P478
45
p:P356
wds:Q43246067-F719E976-5810-4111-A3FF-4C125CE3EC8B
wdtn:P356
n12:BMT.2009.318
wdt:P356
10.1038/BMT.2009.318
p:P5875
wds:Q43246067-875D137F-616B-4C6D-BEE1-33AA8D5C4AD4
wdt:P5875
38075419
p:P6179
wds:Q43246067-13C9E721-EDCD-498A-85D3-2E79094AEE3F
wdt:P6179
1049419940